Preview the system changes
Release information
This document describes the TraceLink capabilities included in the Product Availability Intelligence, version 2024.2 app release, which is available on Validation and Production on 30 Jul 2024.
The following apps are impacted by this release and will be updated to the version listed:
- Product Availability Intelligence, version 2024.2
Solutions supported by this app version:
- Product Availability Intelligence, solution version 2.0
The features below are in order of functional relevance (i.e. the typical order in which a user executes a function or task).
Download the PDF
Use this preview for planning and impact analysis. All information in this preview is subject to change before the final release date. The final documentation is available in conjunction with the Validation release date. The final documentation might include resolved and known issues, if applicable.
Revisions
| Date | Revision | Description |
|---|---|---|
| 02 Jul 2024 | 01 | Initial version. |
API features
There is no new or updated API functionality included in this release.
System features
The following new or updated system functionality will be included in this release.
Display ASHP Copyright Notice in PAI
As a part of the contractual agreement between TraceLink and the American Society of Health-System Pharmacists (ASHP), the following copyright notice will be visible on all the materials or files using or reproducing any part of the Drug Shortage Data:
"Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah, provided by ASHP as its exclusive authorized distributor, and used with permission. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Contract No.: 3.11.337 (a) - 3 – (Final 1.May.2022) ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug."
The copyright notice text is also updated in the existing PAI_Daily_shortage_Predictions_Readme.txt file.
Impact analysis
- Interface options:
- There are no UI or API impacts.
- Business segment impacts:
- Pharmaceutical Manufacturer (Owners only)
- Pharmacy/Hospital (Owners only)
